OTC Markets Group Welcomes EZTD to OTCQX
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial markets, today announced EZTD, Inc. (OTCQX:EZTD), a leading operator of online trading platforms for binary options and FOREX, has qualified to trade on the OTCQX® Best Market in the U.S.
EZTD began trading on OTCQX on December 30, 2015, under the symbol “EZTD.” Investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com .
“Established in 2001, EZTD operates some of the most popular online trading platforms for binary options and FOREX in Europe,” said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group. “We welcome EZTD to the OTCQX market and look forward to helping grow their presence in the U.S. investment community.”
Burns, Figa & Will, P.C. serves as EZTD’s Designated Advisor for Disclosure (“DAD”) on OTCQX, responsible for providing professional guidance on OTCQX requirements.
EZTD’s CEO Shimon Citron said, "We are very pleased to have achieved OTC Markets Group's requirements for its premier securities market. Trading on OTCQX is expected to improve our company’s ability to attract institutional investors from both inside and outside of the United States. This latest corporate milestone should provide additional visibility within the investment community, enabling us to build company awareness and expand the current shareholder base in order to drive shareholder value."
EZTD, through its subsidiaries, develops and operates online trading platforms for the trading of binary options and FOREX. It is the leading provider of binary options trading platforms to retail customers, holding several of the most popular online brokers worldwide. It is fully regulated by CySEC and it adheres to all local (national) compliance requirements for financial services companies.
The company develops all of its own software and platforms, with all research and development done in-house. The company's subsidiaries offer customers a wide range of binary options on more than 120 global assets including stocks, currencies, indices and commodities.
The company was founded in 2001.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected financial markets for 10,000 U.S. and global securities. Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities. We organize these securities into markets to inform investors of opportunities and risks: the OTCQX® Best Market; the OTCQB® Venture Market; and the OTC Pink® Open Market. Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors. To learn more about how we create better informed and more efficient financial markets, visit www.otcmarkets.com .
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.
EZTD Safe Harbor Statement
This press release contains forward-looking statements. In some cases these forward-looking statements can be identified by the use of forward-looking terminology, including the terms “believes,” “estimates,” “anticipates, ”expects,” “plans,” intends,” “may,” “could,” “might,” “will,” “should,” “approximately,” “potential,” or in each case, their negative or other variations thereon or comparable terminology, although not all forward-looking statements contain these words. For example, forward-looking statements are used in this press release when it is discussed that trading on the OTCQX is expected to improve EZTD’s ability to attract institutional investors and that it should provide additional visibility within the investment community, enabling EZTD to build company awareness and expand the current shareholder base in order to drive shareholder value. These forward-looking statements and their implications are based on the current expectations of the management of EZTD, Inc. only, and are subject to a number of factors and uncertainties, many of which are beyond the control of EZTD, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. EZTD undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. For a more detailed description of the risks and uncertainties affecting EZTD, reference is made to the heading "Risk Factors" in EZTD's registration statement on Form 10 filed with the Securities and Exchange Commission.
Harry Chathli, +442076189100
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
PIERRE-FABRE23.6.2018 13:02 | pressemeddelelse
Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress
SERVIER23.6.2018 10:12 | pressemeddelelse
Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho
SOFTOMOTIVE22.6.2018 17:15 | pressemeddelelse
Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA
TX-ASCEND-PERFORMANCE22.6.2018 16:02 | pressemeddelelse
Ascend Performance Materials Announces Price Increase for Intermediate Materials
DELTICOM-AG/MOTO-TYRES.C22.6.2018 15:43 | pressemeddelelse
Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk
BOEHRINGER-INGELHEIM22.6.2018 14:02 | pressemeddelelse
Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum